Advanced search
Publication Cover
Epigenomics Volume 3, 2011 - Issue 2
Submit an article Journal homepage
1,419
Views
0
CrossRef citations to date
0
Altmetric
Editorial

EZH2 and Cancer Stem Cells: Fact or Fiction?

Francesco CreaDepartment of Internal Medicine, Division of Pharmocology, University of Pisa, Italy. Tel.: +39 347 390 8226 Fax: +39 050 221 [email protected]
Pages 127-128 | Published online: 20 Apr 2011

Bibliography

  • Surface LE , ThorntonSR, BoyerLA: Polycomb group proteins set the stage for early lineage commitment.Cell Stem Cell7 , 288–298 (2010).
  • Aoki R , ChibaT, MiyagiSet al.: The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.J. Hepatol.52 , 854–863 (2010).
  • Varambally S , DhanasekaranSM, ZhouMet al.: The polycomb group protein EZH2 is involved in progression of prostate cancer.Nature419 , 624–629 (2002).
  • Crea F , MathewsLA, FarrarWL, HurtEM: Targeting prostate cancer stem cells.Anticancer Agents Med. Chem.9 , 1105–1113 (2009).
  • Suva ML , RiggiN, JaniszewskaMet al.: EZH2 is essential for glioblastoma cancer stem cell maintenance.Cancer Res.69 , 9211–9218 (2009).
  • Orzan F , PellegattaS, PolianiLet al.: Enhancer of zeste 2 (EzH2) is up-regulated in malignant gliomas and in glioma stem-like cells.Neuropathol. Appl. Neurobiol. DOI: doi: 10.1111/j.1365–2990.2010.01132 (2010) (Epub ahead of print).
  • Crea F , HurtEM, FarrarWL: Clinical significance of Polycomb gene expression in brain tumors.Mol. Cancer9 , 265 (2010).
  • Wang H , OuyangY, SomersWG, ChiaW, LuB: Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating Pon.Nature449 , 96–100 (2007).
  • Yu J , YuJ, RhodesDRet al.: A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.Cancer Res.67 , 10657–10663 (2007).
  • Berezovska OP , GlinskiiAB, YangZ, LiXM, HoffmanRM, GlinskyGV: Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.Cell Cycle5 , 1886–1901 (2006).
  • Hurt EM , FarrarWL: Cancer stem cells: the seeds of metastasis?Mol. Interv.8 , 140–142 (2008).
  • Yasuda H , SoejimaK, WatanabeHet al.: Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.Int. J. Oncol.37 , 1537–1546 (2010).
  • Hurt EM , KawasakiBT, KlarmannGJ, ThomasSB, FarrarWL: CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.Br. J. Cancer98 , 756–765 (2008).
  • Dick JE : Looking ahead in cancer stem cell research.Nat. Biotechnol.27 , 44–46 (2009).
  • Cao Q , YuJ, DhanasekaranSMet al.: Repression of E-cadherin by the polycomb group protein EZH2 in cancer.Oncogene27 , 7274–7284 (2008).
  • Mathews LA , HurtEM, ZhangX, FarrarWL: Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.Mol. Cancer9 , 267 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.